Paper6969693
Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin).
Krasemann C and 5 others. Infection, 1980. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin). Papers, record 6969693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6969693
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin).
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteroidaceae | Major topic |
| Cephalosporins | Major topic |
| Microbial Sensitivity Tests | Major topic |
| Peptococcaceae | Major topic |
| Cefamandole | |
| Cefazolin | |
| Cefoxitin | |
| beta-Lactamases |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 168701 | [A new butyric acid-producing bacteroides species: B. splanchnicus n. sp. (author's transl)]. | Zentralbl Bakteriol Orig A | 1975 | https://conductscience.org/library/papers/168701 | PubMed |
| 2 | 949182 | Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/949182 | PubMed |
| 3 | 984809 | Susceptibility of anaerobic bacteria to 23 antimicrobial agents. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984809 | PubMed |
| 4 | 4210470 | Differentiation and medical importance of saccharolytic intestinal Bacteroides. | Arzneimittelforschung | 1974 | https://conductscience.org/library/papers/4210470 | PubMed |
| 5 | 5083607 | A comparative study of 55 Sphaerophorus strains. Differentiation of 3 species: Sphaerophorus necrophorus, Sph, varius, and Sph. freundii. | Med Microbiol Immunol | 1972 | https://conductscience.org/library/papers/5083607 | PubMed |
| 6 | 5147789 | A biochemical study of fusiform anaerobes. | Med Microbiol Immunol | 1971 | https://conductscience.org/library/papers/5147789 | PubMed |
| 7 | 314805 | Susceptibility to cefazedone and cefazolin and production of beta-lactamase in in Bacteroides fragilis and other species of Bacteroidaceae. | Arzneimittelforschung | 1979 | https://conductscience.org/library/papers/314805 | PubMed |
| 8 | 45494 | Purification and properties of beta-lactamase from Bacteroides fragilis. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/45494 | PubMed |
| 9 | 938021 | Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/938021 | PubMed |
| 10 | 1179870 | [Susceptibility to tetracycline and doxycycline of 80 strains of Bacteroides fragilis, B, thetaiotaomicron, and B. vulgatus mostly isolated in 1973/74 (author's transl)]. | Zentralbl Bakteriol Orig A | 1975 | https://conductscience.org/library/papers/1179870 | PubMed |
| 11 | 856025 | Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/856025 | PubMed |
| 12 | 4146824 | [Anaerobic gram-positive cocci (Peptococcus variabilis, P. asaccharolyticus, P. prevotii and P. saccharolyticus) isolated from pathological material]. | Zentralbl Bakteriol Orig A | 1973 | https://conductscience.org/library/papers/4146824 | PubMed |
| 13 | 1180547 | Comparison of cefoxitin and cephalothin therapy of a mixed Bacteroides fragilis and Fusobacterius necrophorum infection in mice. | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/1180547 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 8051254 | Evaluation of Alamar colorimetric MIC method for antimicrobial susceptibility testing of gram-negative bacteria. | J Clin Microbiol | 1994 | https://conductscience.org/library/papers/8051254 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6969693
GET https://conductscience.org/api/papers/v1/6969693/authors